Meta-analysis of Esomeprazole-Based Triple Therapies in Helicobacter Pylori Eradication

BAO Zhi-jun,HUANG Yi-qin,ZHENG Song-bai,ZHANG Gan-sheng,YU Xiao-feng,WANG Gen-sheng,ZHU Yue
DOI: https://doi.org/10.3969/j.issn.1007-7669.2007.01.012
2007-01-01
Abstract:AIM:To compare the efficacies of esomeprazole-based and other proton pump inhibitors based triple therapies in Helicobacter pylori(Hp) eradication.METHODS:The published studies were iden- tified by searching the MEDLINE (January 1966 to June 2005) and EMBASE (January 1988 to June 2005) electronic databases and reviewing the bibliographies of the collected articles to find additional relevant studies. Studies evaluating esomeprazole-based therapies were accepted.Only randomized trials comparing esomeprazole and other proton pump inhibitors plus antibiotics,and differing only proton pump inhibitor were included in our meta-analysis.Information on region of origin,sample quantity,duration of studies,therapeutic formula and Hp eradication rates were extracted through a standardized protocol.RESULTS:Mean eradication rates with triple regimens according to intention-to-treat and per-protocol (esomeprazole plus clarithromycin and either amoxieillin or metronidazole) were 82.1% and 86.1%,respectively.Five high quality studies included Meta- analysis showed mean Hp eradication rates (intention-to-treat) with esomeprazole plus antibiotics were 84.2%, and omeprazole 82.0%,showing odds ratio 1.17 and 95% confidence interval 0.88-1.56.Results were statis- tically in equal.CONCLUSION:Esomeprazole-based triple therapy is highly effective for the eradication of Hp infection and offers comparable efficacy to omeprazole-based therapy.
What problem does this paper attempt to address?